Try our Advanced Search for more refined results
March 18, 2022
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al
Case Number:
1:22-cv-02229
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
October 05, 2022
Developers Tied To Pfizer COVID Vaccine Want IP Suit Tossed
Two developers of the mRNA delivery system used in Pfizer and BioNTech's COVID-19 vaccine have urged a New York federal judge to toss a suit from Acuitas Therapeutics Inc. seeking a declaration that the sale of Pfizer's COVID-19 Comirnaty vaccine does not infringe nine of the developers' patents.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login